• Yichao Yang, Kristina M Feye, Zhaohao Shi, Hilary O Pavlidis, Michael Kogut, Amanda J Ashworth, and Steven C Ricke.
• Department of Poultry Science, University of Arkansas Fayetteville, Fayetteville, AR, United States.
• Front Microbiol. 2019 Jan 1; 10: 1509.

AbstractCampylobacter is one of the most commonly reported foodborne human bacterial gastrointestinal pathogens. Campylobacter is the etiological agent of campylobacteriosis, which is generally a self-limited illness and therefore does not require treatment. However, when patients are immunocompromised or have other co-morbidities, antimicrobial treatment may be necessary for clinical treatment of campylobacteriosis, macrolides and fluoroquinolones are the drugs of choices. However, the increase in antimicrobial resistance of Campylobacter to clinically important antibiotics may become insurmountable. Because of the transmission between poultry and humans, the poultry industry must now allocate resources to address the problem by reducing Campylobacter as well as antimicrobial use, which may reduce resistance. This review will focus on the incidence of antibiotic-resistant Campylobacter in poultry, the clinical consequences of this resistance, and the mechanisms of antibiotic resistance associated with Campylobacter.

5 keywords...

hide…